Structural properties of matrix metalloproteinases

Cellular and Molecular Life Sciences

Volumn 55, Issue 4, 1999, Pages 639-652

  Bode, W ^a   Fernandez Catalan, C ^a   Tschesche, H ^b   Grams, F ^d   Nagase, H ^c   Maskos, K ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b BIELEFELD UNIVERSITY   (Germany)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Crystal structures; Drug design; Matrix metalloproteinases (MMPs); Proteinases; Tissue inhibitors of metalloproteinases (TIMPs)

Indexed keywords

MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTHRITIS; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FOLDING; REVIEW; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANIMALS; CATALYTIC DOMAIN; EXTRACELLULAR MATRIX PROTEINS; HEMOPEXIN; HUMANS; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0032951138     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050320     Document Type: Review

References (89)

1. Woessner J. F. Jr. (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145-2155
2. Nagase, H., Das, S. K., Dey, S. K., Fowlkes, J. L., Huang, W. and Brew, K. (1997) In: Inhibitors of Metalloproteinases in Development and Disease, Hawkes S. P., Edwards D. R. and Khokha R. (eds), Harwood, Lausanne
3. Johnson L. L., Dyer R. and Hupe D. J. (1998) Matrix metalloproteinases. Curr. Opin. Chem. Biol. 2: 466-471
4. Yong V. W., Krekoski C. A., Forsyth P. A., Bell R. and Edwards D. R. (1998) Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21: 75-80
5. Coussens L. M. and Werb Z. (1996) Matrix metalloproteinases and the development of cancer. Chem. Biol. 3: 895-904
6. Chambers A. F. and Matrisian L. M. (1997) Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89: 1260-1270
7. Beckett R. and Whittaker M. (1998) Matrix metalloproteinase inhibitors 1998. Exp. Opin. Ther. Patents 8: 259-282
8. Bottomley K. M., Johnson W. H. and Walter D. S. (1998) Matrix metalloproteinase inhibitors in arthritis. J. Enz. Inhib. 13: 79-101
9. Massova I., Kotra L. P., Fridman R. and Mobashery S. (1998) Matrix metalloproteinases: structures, evolution and diversification. FASEB J. 12: 1075-1095
10. Rawlings N. D. and Barrett A. J. (1995) Evolutionary families of metallopeptidases. Methods Enzymol. 248: 183-229
11. Sang Q. A. and Douglas D. A. (1996) Computational sequence analysis of matrix metalloproteinases. J. Prot. Chem. 15: 137-160
12. Murphy G. J., Murphy G. and Reynolds J. J. (1991) The origin of matrix metalloproteinases and their familial relationships. FEBS Lett. 289: 4-7
13. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E. et al. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65
14. Sato H., Kinoshita T., Takino T., Nakayama K. and Seiki M. (1996) Activation of a recombinant membrane type I-matrix metalloproteinase (MTI-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett. 393: 101-104
15. Pei D. and Weiss S. J. (1996) Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271: 9135-9140
16. Murphy G. and Knäuper V. (1997) Relating matrix metalloproteinase structure to function: why the 'hemopexin' domain? Matrix Biol. 15: 511-518
17. Goldberg G. I., Wilhelm S. M., Kronberger A., Bauer E. A., Grant G. A. and Eisen A. Z. (1986) Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J. Biol. Chem. 261: 6600-6605
18. Wilhelm S. M., Collier I. E., Kronberger A., Eisen A. Z., Marmer B. L., Grant G. A. et al. (1987) Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity and differential expression in normal and tumorigenic cells. Proc. Natl. Acad. Sci. USA 84: 6725-6729
19. Muller D., Quantin B., Gesnel M.-C., Millon-Collard R., Abecassis J. and Breathnach R. (1988) The collagenase gene family in humans consists of at least four members. Biochem. J. 253: 187-192
20. Hasty K. A., Pourmotabbed T. F., Goldberg G. I., Thompson J. P., Spinella D. G., Stevens R. M. et al. (1990) Human neutrophil collagenase. A distinct gene product with homology to other metalloproteinases. J. Biol. Chem. 265: 11421-11424
21. Okada A., Bellocq J.-P., Royer N., Chenard M.-P., Rio M.-C., Chambon P. et al. (1995) Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast and head and neck carcinomas. Proc. Natl. Acad. Sci. USA 92: 2730-2734
22. Fernandez-Catalan C., Bode W., Huber R., Turk D., Calvete J. J., Lichte A. et al. (1998) Crystal structure of the complex formed by the membrane type I-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO J. 17: 5238-5248
23. Douglas D. A., Shi Y. E. and Sang Q. A. (1997) Computational sequence analysis of the tissue inhibitor of metalloproteinase family. J. Prot. Chem. 16: 237-255
24. Gomez D. E., Alonso D. F., Yoshiji H. and Thorgeirsson U. P. (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74: 111-122
25. Cawston T. (1998) Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. Mol. Med. Today 4: 130-137
26. Butler G. S., Will H., Atkinson S. J. and Murphy G. (1997) Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproeinases. Eur. J. Biochem. 244: 653-657
27. Will H., Atkinson S. J., Butler G. S., Smyth B. and Murphy G. (1996) The soluble catalytic domain of membrane type I matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autocatalytic activation. J. Biol. Chem. 271: 17119-17123
28. Zucker S., Drews M., Conner C., Foda H. D., DeClerck Y. A., Langley K. E. et al. (1998) Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type I-matrix metalloproteinase I (MTI -MMP). J. Biol. Chem. 273: 1216-1222
29. Murphy G. and Willenbrock F. (1995) Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol. 248: 496-510
30. Strongin A. Y., Collier I. E., Bannikov U., Marmer B. L., Grant G. A. and Goldberg G. I. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. J. Biol. Chem. 270: 5331-5338
31. Strongin A. Y., Marmer B. L., Grant G. A. and Goldberg G. I. (1993) Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem. 268: 14033-14039
32. Kinoshita T., Sato H., Takino T., Itoh M., Akizawa T. and Seiki M. (1996) Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type I matrix metalloproteinase. Cancer Res. 56: 2535-2538
33. Huang W., Meng Q., Suzuki K., Nagase H. and Brew K. (1997) Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases I (TIMP-1) locates an inhibitory region for matrix metalloproteinases. J. Biol. Chem. 272: 22086-22091
34. Murphy G., Houbrechts A., Cockett M. I., Williamson R. A., O'Shea M. and Docherty A. J. P. (1991) The N-terminal domain of human tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 30: 8097-8102
35. Lovejoy B., Cleasby A., Hassell A. M., Longley K., Luther M. A., Weigl D. et al. (1994) Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science 263: 375-377
36. Borkakoti N., Winkler F. K., Williams D. H., D'Arey A., Broadhurst M. J., Brown P. A. et al. (1994) Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor. Nature Struct. Biol. 1: 106-110
37. Stams T., Spurlino J. C., Smith D. L., Wahl R. C., Ho T. F., Qoronfleh M. W. et al. (1994) Structure of human neutrophil collagenase reveals large Sl' specificity pocket. Nature Struct. Biol. 1: 119-123
38. Bode W., Reinemer P., Huber R., Kleine T., Schnierer S. and Tschesche H. (1994) The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J. 13: 1263-1269
39. Reinemer P., Grams F., Huber R., Kleíne T., Schnierer S., Pieper M. et al. (1994) Structural implications for the role of the N-terminus in the 'superactivation' of collagenases - a crystallographic study. FEBS Lett. 338: 227-233
40. Gooley P. R., O'Connell J. F., Marcy A. I., Cuca G. C., Salowe S. P., Bush B. L. et al. (1994) NMR structure of inhibited catalytic domain of human stromelysin-1. Nature Struct. Biol. 1: 111-118
41. Lovejoy B., Hassell A. M., Luther M. A., Weigl D. and Jordan S. R. (1994) Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself. Biochemistry 33: 8207-8217
42. Spurlino J. C., Smallwood A. M., Carlton D. D., Banks T. M., Vavra K. J., Johnson J. S. et al. (1994) 1.56 Å structure of mature truncated human fibroblast collagenase. Proteins: Struct. Funct. Genet. 19: 98-109
43. Browner M. F., Smith W. W. and Castelhano A. L. (1995) Matrilysin-inhibitor complexes: common themes among metalloproteases. Biochemistry 34: 6602-6610
44. Becker J. W., Marcy A. I., Rokosz L. L., Axel M. G., Burbaum J. J., Fitzgerald P. M. D. et al. (1995) Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Prot. Sci. 4: 1966-1976
45. Dhanaraj V., Ye Q.-Z., Johnson L. L., Hupe D. J., Ortwine D. F., Dunbar J. B. et al. (1996) X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily. Structure 4: 375-386
46. vanDoren S. R., Kurochkin A. V., Hu W., Ye Q. Z., Johnson L. L., Hupe D. J. et al. (1995) Solution structure of the catalytic domain of human stromelysin completed with a hydrophobic inhibitor. Protein Sci. 4: 2487-2498
47. Wetmore D. R. and Hardman K. D. (1996) Roles of the propeptide and metal ions in the folding and stability of the catalytic domain of stromelysin (matrix metalloproteinase 3). Biochemistry 35: 6549-6558
48. Gomis-Rüth F. X., Maskos K., Betz M., Bergner A., Huber R., Suzuki K. et al. (1997) Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389: 77-81
49. Grams F., Reinemer P., Powers J. C., Kleine T., Pieper M., Tschesche H. et al. (1995) X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design. Eur. J. Biochem. 228: 830-841
50. Grams F., Crimmin M., Hinnes L., Huxley P., Pieper M., Tschesche H. et al. (1995) Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor. Biochemistry 34: 14012-14020
51. Li J.-Y., Brick P., O'Hare M. C., Skarzynski T., Lloyd L. F., Curry V. A. et al. (1995) Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed β-propeller. Structure 3: 541-549
52. Libson A., Gittis A., Collier I., Marmer B., Goldberg G. and Lattman E. E. (1995) Crystal structure of the hemopexin-like C-terminal domain of gelatinase A. Nature Struct. Biol. 2: 938-942
53. Gohlke U., Gomis-Rüth F.-X., Crabbe T., Murphy G., Docherty A. J. P. and Bode W. (1996) The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP2): structural implications for its function. FEBS Lett. 378: 126-130
54. Gomis-Rüth F. X., Gohlke U., Betz M., Knäuper V., Murphy G. Lopez-Otin C. et al. (1996) The helping hand of collagenase-3 (MMP-13): 2.7 Å crystal structure of its C-terminal haemopexin-like domain. J. Mol. Biol. 264: 556-566
55. Bode W. (1995) A helping hand for collagenases: the haemopexin-like domain. Structure 3: 527-530
56. Williamson R. A., Martorell G., Carr M. D., Murphy G., Docherty A. J., Freedman R. B. et al. (1994) Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family. Biochemistry 33: 11745-11759
57. Williamson R. A., Carr M. D., Frenkiel T. A., Feeney J. and Freedman R. B. (1997) Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation. Biochemistry 36: 13882-13889
58. Muskett F. W., Frenkiel T. A., Feeney J., Freedman R. B., Carr M. D. and Williamson R. (1998) High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3. J. Biol. Chem. 273: 2173-21743
59. Schechter I. and Berger A. (1967) On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27: 157-162
60. Bode W., Gomis-Rüth F.-X. and Stöcker W. (1993) Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXX-HXXGXXII and Met-turn) and topologies and should be grouped into a common family, the 'metzineins'. FEBS Lett. 331: 134-140
61. Stöcker W., Grams F., Baumann U., Reinemer P., Gomis-Rüth F. X., McKay D. B. et al. (1995) The metzincins - topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci. 4: 823-840
62. Pickford A. R., Potts J. R., Bright J. R., Phan I. and Campbell I. D. (1997) Solution structure of a type 2 module from fibronectin: implications for the structure and function of the gelatin-binding domain. Structure 5: 359-370
63. Knäuper V., Murphy G. and Tschesche H. (1996) Activation of human neutrophil procollagenase by stromelysin 2. Eur. J. Biochem. 235: 187-191
64. Suzuki K., Enghild J. J., Morodomi T., Salvesen G. and Nagase H. (1990) Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29: 10261-10270
65. Nagase H. (1997) Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378: 151-160
66. Pieper M., Betz M., Budisa N., Gomis-Rüth F.-X., Bode W. and Tschesche H. (1997) Expression, purification, characterization and X-ray analysis of selenomethionine 215 variant of leukocyte collagenase. J. Protein Chem. 16: 637-650
67. Netzel-Arnett S., Fields G. B., Birkedal-Hansen H. and van Wart H. E. (1991) Sequence specificities of human fibroblast and neutrophil collagenase. J. Biol. Chem. 266: 6747-6755
68. Netzel-Arnett S., Sang Q. X., Moore W. G. I., Navre M., Birkedal-Hansen H. and van Wart H. E. (1993) Comparative sequence specificities of human 72-and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). Biochemistry 32: 6427-6432
69. Niedzwiecki L., Teahan J., Harrison R. K. and Stein R. L. (1992) Substrate specificity of the human matrix metalloproteinase stromelysin and the development of continuous fluoremetric assays. Biochemistry 31: 12618-12623
70. Birkedal-Hansen H., Moore W. G. I., Bodden M. K., Windsor L. J., Birkedal-Hansen B., DeCarlo A. et al. (1993) Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4: 197-250
71. Matthews B. W. (1988) Structural basis of the action of thermolysin and related zinc peptidases. Acc. Chem. Res. 21: 333-340
72. Crabbe T., Zucker S., Cockett M. I., Willenbrock F., Tickle S., O'Connell J. P. et al. (1994) Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis and the binding of tissue inhibitor of metalloproteinases-1. Biochemistry 33: 6684-6690
73. Windsor L. J., Bodden M. K., Birkedal-Hansen B., Engler J. A. and Birkedal-Hansen H. (1994) Mutational analysis of residues in and around the active site of human fibroblast-type collagenase. J. Biol. Chem. 269: 26201-26207
74. Bode W., Gomis-Rüth F. X., Huber R., Zwilling R. and Stöcker W. (1992) Structure of astacin and implications for activation of astacins and zinc ligation of collagenases. Nature 358: 164-166
75. Grams F., Dive V., Yiotakis A., Yiallouros I., Vassiliou S., Zwilling R. et al. (1996) Structure of astacin with a transition-state analogue inhibitor. Nature Struct. Biol. 3: 671-675
76. Noel A., Santavicca M., Stoll I., L'Hoir C., Staub A., Murphy G. et al. (1995) Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities. J. Biol. Chem. 270: 22866-22872
77. Nicholls A., Bharadwaj R. and Honig B. (1993) Grasp-graphical representation and analysis of surface properties. Biophys. J. 64: A166
78. van Wart H. E. and Birkedal-Hansen H. (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA 87: 5578-5582
79. Faber H. R., Groom C. R., Baker H. M., Morgan W. T., Smith A. and Baker E. N. (1995) 1.8 À crystal structure of the C-terminal domain of rabbit serum haemopexin. Structure 3: 551-559
80. Murphy G., Allan J. A., Willenbrock F., Cockett M. I., O'Connell J. P. and Docherty A. J. P. (1992) The role of the C-terminal domain in collagenase and stromelysin specificity. J. Biol. Chem. 267: 9612-9618
81. Sanchez-Lopez R., Alexander C. M., Behrendtsen O., Breathnach R. and Werb Z. (1993) Role of zinc-binding-and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins. J. Biol. Chem. 268: 7238-7247
82. Hirose T., Patterson C., Pourmotabbed T., Mainardi C. L. and Hasty K. A. (1993) Structure-function relationship of human neutrophil collagenase: identification of regions responsible for substrate specificity and general proteinase activity. Proc. Natl. Acad. Sci. USA 90: 2569-2573
83. Ohuchi E., Imai K., Fujii Y., Sato H., Seiki M. and Okada Y. (1997) Membrane type I matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272: 2446-2451
84. Knäuper V., Docherty A. J. P., Smith B., Tschesche H. and Murphy G. (1997) Analysis of the contribution of the hinge region of human neutrophil collagenase (HNC, MMP-8) to stability and collagenolytic activity by alanine scanning mutagenesis. FEBS Lett. 405: 60-64
85. Ottl J., Battistuta R., Pieper M .,Tschesche H., Bode W., Kühn K. et al. (1996) Design and synthesis of heterotrimeric collagen peptides with a built-in cystine knot. FEBS Lett. 398: 31-36
86. Cao J., Sato H.,Takino T. and Seiki M. (1995) The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for progelatinase A activation. J. Biol. Chem. 270: 801-805
87. Butler G. S., Butler M. J., Atkinson S. J., Will H., Tamura T., van Westrum S. S. et al. (1998) The TIMP2 membrane type I metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. J. Biol. Chem. 273: 871-880
88. Evans S. V. (1993) SETOR: hardware lighted three-dimensional solid model representations of macromolecules. J. Mol. Graph. 11: 134-138
89. Barton G. J. (1993) ALSCRIPT: a tool to format multiple sequence alignments. Protein Eng. 6: 37-40